Investors





News Release

Printer Friendly Version View printer-friendly version
<< Back
PetIQ, Inc. Announces Appointment of R. Michael Herrman as General Counsel
Veteran Boehringer Ingelheim Attorney to Guide PetIQ’s Growing Presence in Animal Health Industry

EAGLE, Idaho, Feb. 25, 2019 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced the appointment of R. Michael Herrman as General Counsel, effective February 18, 2019.  Mr. Herrman has practiced law for more than 20 years within the life sciences industry.  He has spent the last 16 years at Boehringer Ingelheim with 12 years in its Animal Health business – the second largest biological and pharmaceutical animal health company in the world.

Cord Christensen, PetIQ’s Chairman and Chief Executive Officer, commented, “We are pleased to welcome Michael to our management team.  Michael’s tenure at Boehringer Ingelheim, specifically within its animal health business, are of tremendous value to PetIQ as we execute on our long-term growth strategy in the animal health industry.  We look forward to his future contributions.”

Since Mr. Herrman joined Boehringer Ingelheim's Animal Health business in 2007, it grew from the 10th largest global biological and pharmaceutical animal health company to the second largest in the world.  Mr. Herrman most recently served as Head of Legal for Boehringer Ingelheim’s Latin America Animal Health region since 2017 and prior to that as the Head of Legal in the United States Animal Health business since 2007. During his time with Boehringer Ingelheim he has been a key contributor to  numerous mergers, acquisitions and divestiture activities, which were transformative to its Animal Health business.  Mr. Herrman served in leadership roles for the acquisition of a substantial portion of the Fort Dodge® Animal Health assets from Pfizer®, Inc./Zoetis®, Inc., more than doubling the size of the Animal Health business in 2009 and the acquisition of Merial®, Inc. from Sanofi in 2017. 

About PetIQ
PetIQ is a leading, rapidly growing pet health and wellness company.  Through over 60,000 points of distribution across retail and e-commerce channels, PetIQ and VIP Petcare, a wholly-owned subsidiary, have a mission to make pet lives better by educating pet parents on the importance of offering regular, convenient access and affordable choices for pet preventive and wellness veterinary products and services.  PetIQ believes that pets are an important part of the family and deserve the best products and care we can give them.  For more information, visit www.PetIQ.com.

Contacts:

Investor Relations Contact:
ICR
Katie Turner
katie.turner@icrinc.com
Jeff Sonnek
646-277-1263
jeff.sonnek@icrinc.com

Media Relations Contact:
ICR
Cory Ziskind
646-277-1232
cory.ziskind@icrinc.com

 

PETIQ.png

PetIQ, Inc.